Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.
暂无分享,去创建一个
Efstathios Karathanasis | Mark A Griswold | Randall Toy | Lisa Bauer | M. Griswold | R. Keri | L. Bauer | Elliott Hayden | Emily Tran | Jenna Pansky | Pubudu M Peiris | R. Toy | P. Peiris | E. Karathanasis | Ruth A Keri | Elizabeth Doolittle | Aaron Mayer | E. Tran | J. Pansky | E. Doolittle | E. Schmidt | E. Hayden | A. Mayer | Erik Schmidt
[1] Xin Cai,et al. A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release. , 2011, Journal of the American Chemical Society.
[2] F. Yuan,et al. Transvascular drug delivery in solid tumors. , 1998, Seminars in radiation oncology.
[3] M. Dewhirst,et al. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.
[4] A. Gabizon,et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[5] C. Sammons. Liposomal Anthracyclines for Breast Cancer: Overview , 2003 .
[6] W. Cowden,et al. Angiogenesis and Heparanase Activity Assays for in Vitro Tumor Growth and Metastasis Using Novel Identification of Sulfated Oligosaccharide-based Inhibitors of Updated Version , 1999 .
[7] S. Giri,et al. Pharmacokinetics, covalent binding and subcellular distribution of [3H]doxorubicin after intravenous administration in the mouse. , 1981, The Journal of pharmacology and experimental therapeutics.
[8] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[9] L. Chodosh,et al. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. , 2011, Neoplasia.
[10] Y. Barenholz,et al. Ammonium Sulfate Gradients for Efficient and Stable Remote Loading of Amphipathic Weak Bases into Liposomes and Ligandoliposomes. , 1994 .
[11] Younan Xia,et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light , 2009, Nature materials.
[12] Efstathios Karathanasis,et al. Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy. , 2008, Biomaterials.
[13] P. Rose,et al. Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer. , 2005, The oncologist.
[14] Y. Sawada,et al. Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D. , 1984, Journal of pharmacobio-dynamics.
[15] Paul A Dayton,et al. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[16] R. Jain,et al. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.
[17] R. Bellamkonda,et al. Rational identification of a novel peptide for targeting nanocarriers to 9L glioma. , 2008, Journal of biomedical materials research. Part A.
[18] Zhong-gao Gao,et al. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. , 2007, Journal of the National Cancer Institute.
[19] L. Lo,et al. Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release , 2009, Nanotechnology.
[20] Mi Ae Kim,et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype , 2005, Oncogene.
[21] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[22] A. Mazar,et al. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428. , 1997, Cancer research.
[23] A. Gabizon,et al. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[24] Efstathios Karathanasis,et al. Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers , 2009, PloS one.
[25] D. Tzemach,et al. Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals , 1997 .
[26] R. Bellamkonda,et al. Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. , 2009, Radiology.
[27] A. Ballangrud,et al. Binding and interstitial penetration of liposomes within avascular tumor spheroids , 2004, International journal of cancer.
[28] Michael J Sailor,et al. Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. , 2009, Small.
[29] S. Campos. Liposomal anthracyclines: adjuvant and neoadjuvant therapy for breast cancer. , 2003, The oncologist.
[30] D. Discher,et al. Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.
[31] M. Sehested,et al. Culprit and victim -- DNA topoisomerase II. , 2002, The Lancet. Oncology.
[32] Heng Huang,et al. Remote control of ion channels and neurons through magnetic-field heating of nanoparticles. , 2010, Nature nanotechnology.
[33] John B Weaver,et al. Concurrent quantification of multiple nanoparticle bound states. , 2011, Medical physics.
[34] R. Bellamkonda,et al. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. , 2009, Biomaterials.
[35] M. Israel,et al. Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells. , 1981, Cancer research.
[36] Daniel Day,et al. Cancer cell imaging and photothermal therapy using gold nanorods , 2008 .
[37] Alexander O. Govorov,et al. Generating heat with metal nanoparticles , 2007 .
[38] L. Liu,et al. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.
[39] Liposomal anthracyclines in metastatic breast cancer: clinical update. , 2003, The oncologist.
[40] R. Jain,et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.
[41] D. Niethammer,et al. Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). , 1998, International journal of molecular medicine.
[42] R. B. Campbell,et al. Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[43] Jinwoo Cheon,et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. , 2011, Nature nanotechnology.
[44] I. Tannock,et al. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. , 2006, Cancer research.
[45] R. Bellamkonda,et al. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. , 2011, ACS nano.
[46] Sérgio Simões,et al. On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.
[47] Hairong Zheng,et al. Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[48] D. V. Von Hoff,et al. Risk factors for doxorubicin-induced congestive heart failure. , 1979, Annals of internal medicine.
[49] D. Lasič,et al. Doxorubicin in sterically stabilized liposomes , 1996, Nature.
[50] Uchiyama,et al. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. , 1999, Advanced drug delivery reviews.
[51] Samir Mitragotri,et al. Polymer particle shape independently influences binding and internalization by macrophages. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[52] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[53] P. Peiris,et al. Assembly of Linear Nano-Chains from Iron Oxide Nanospheres with Asymmetric Surface Chemistry , 2011, PloS one.
[54] T. Allen,et al. Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei inMurine Breast , 2005 .
[55] C. Hunt. Liposomes disposition in vivo. V. Liposome stability in plasma and implications for drug carrier function. , 1982, Biochimica et biophysica acta.
[56] J. Shumaker-Parry,et al. Asymmetrically functionalized gold nanoparticles organized in one-dimensional chains. , 2008, Nano letters.
[57] Y. Barenholz,et al. Gelation of liposome interior A novel method for drug encapsulation , 1992, FEBS letters.
[58] Yu Zhang,et al. Gold nanocages covered with thermally-responsive polymers for controlled release by high-intensity focused ultrasound. , 2011, Nanoscale.
[59] S. Bhatia,et al. Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging , 2008, Advanced materials.
[60] Q. Huo,et al. A "nanonecklace" synthesized from monofunctionalized gold nanoparticles. , 2005, Journal of the American Chemical Society.
[61] C. Brazel. Magnetothermally-responsive Nanomaterials: Combining Magnetic Nanostructures and Thermally-Sensitive Polymers for Triggered Drug Release , 2009, Pharmaceutical Research.